A Clinical Study of PA5 in Patients With Advanced Solid Tumors
Clinical trial NCT07702162 · RECRUITING
Trial details
- NCT number
- NCT07702162
- Sponsor
- Chongqing Peg-Bio Biopharm Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-14
- Primary completion
- 2027-02-02
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.